4.05
0.15 (3.85%)
| 前收盘价格 | 3.90 |
| 收盘价格 | 3.82 |
| 成交量 | 493,355 |
| 平均成交量 (3个月) | 188,185 |
| 市值 | 590,861,504 |
| 价格/销量 (P/S) | 22.31 |
| 股市价格/股市净资产 (P/B) | 2.10 |
| 52周波幅 | |
| 利润日期 | 29 Sep 2025 |
| 营业利益率 (TTM) | -384.43% |
| 稀释每股收益 (EPS TTM) | -3.63 |
| 季度收入增长率 (YOY) | -29.90% |
| 流动比率 (MRQ) | 0.920 |
| 营业现金流 (OCF TTM) | -85.93 M |
| 杠杆自由现金流 (LFCF TTM) | -56.25 M |
| 资产报酬率 (ROA TTM) | -63.60% |
| 股东权益报酬率 (ROE TTM) | -1,642.75% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Inventiva S.A. - American Depos | 看跌 | 混合的 |
AIStockmoo 评分
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.13 |
|
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 机构持股比例 | 5.09% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 26.00 (Piper Sandler, 541.98%) | 购买 |
| 中 | 20.00 (393.83%) | |
| 低 | 11.00 (Guggenheim, 171.61%) | 购买 |
| 平均值 | 18.80 (364.20%) | |
| 总计 | 5 购买 | |
| 平均价格@调整类型 | 4.95 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Guggenheim | 18 Nov 2025 | 11.00 (171.60%) | 购买 | 4.00 |
| 02 Sep 2025 | 13.00 (220.99%) | 购买 | 5.26 | |
| Wolfe Research | 06 Nov 2025 | 13.00 (220.99%) | 购买 | 4.18 |
| HC Wainwright & Co. | 09 Oct 2025 | 24.00 (492.59%) | 购买 | 5.53 |
| 03 Sep 2025 | 20.00 (393.83%) | 购买 | 5.77 | |
| Canaccord Genuity | 30 Sep 2025 | 20.00 (393.83%) | 购买 | 5.79 |
| Piper Sandler | 27 Aug 2025 | 26.00 (541.98%) | 购买 | 5.23 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合